Warns of consequences of no deal
RPI, tax avoidance and biodiversity
'Optimisation' plans to reduce costs
Launching on International Women's Day
When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.
UK equities had a positive start to 2019. While this can be partly viewed as a rebound after 2018's difficult final quarter, what is likely to have been most significant is an extraordinary U-turn by the US Federal Reserve.
Optimism ahead of 29 March exit date
Total net inflows of £42.6bn
Brexit continues to dominate the headlines, with the overall prognosis no clearer.
Turned over 40% of fund
We are all tired of talking about backstops and customs unions and voting blocs, but Brexit chat still manages to get centre stage to the exclusion of all else.
Down from 0.6% in Q3 2018
Bear markets more common than investors think
Would reduce investor payments by £1bn a year
Based in London
Accuses Department for International Trade of complacency
Will develop wholesale client base
While our politicians, the media and many investors have their attention fixated on the Brexit negotiations, UK management teams have been getting on with the day job - and deal-making is on the agenda.
Maintains delegation standards
Statutory instruments to be enforced from 29 March
Follows last night's vote
Sterling fell by as much as 0.7%
Retailers surprised analysts with Christmas trading